The U.K.'s <em>Sky News</em> city editor says that AstraZeneca is highlighting all its "hidden gems" in long-term development as evidence for investors to give Pfizer's $106 billion buyout offer a pass.
written on 05.05.2014
AstraZeneca aims to fight Pfizer deal by burnishing its pipeline prospects
